20
Mylan Laboratories Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AZATHIOPRINE USP, with a corresponding US DMF Number 23737.
Remarkably, this DMF maintains an Active status since its submission on April 26, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 04, 2013, and payment made on March 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II